Source: Current Cancer Drug Targets. Unidade: IQ
Subjects: OLIGONUCLEOTÍDEOS, PEPTÍDEOS, PROTEÍNAS, BIOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FARIA, M. e ULRICH, Henning. The use of synthetic oligonucleotides as protein inhibitors and anticode drugs in cancer therapy: accomplishments and limitations. Current Cancer Drug Targets, v. 2, n. 4, p. 355-368, 2002Tradução . . Acesso em: 30 set. 2024.APA
Faria, M., & Ulrich, H. (2002). The use of synthetic oligonucleotides as protein inhibitors and anticode drugs in cancer therapy: accomplishments and limitations. Current Cancer Drug Targets, 2( 4), 355-368.NLM
Faria M, Ulrich H. The use of synthetic oligonucleotides as protein inhibitors and anticode drugs in cancer therapy: accomplishments and limitations. Current Cancer Drug Targets. 2002 ; 2( 4): 355-368.[citado 2024 set. 30 ]Vancouver
Faria M, Ulrich H. The use of synthetic oligonucleotides as protein inhibitors and anticode drugs in cancer therapy: accomplishments and limitations. Current Cancer Drug Targets. 2002 ; 2( 4): 355-368.[citado 2024 set. 30 ]
